# Effect of Melatonin on Cardiometabolic Risk- FULL

> **NCT02681887** · PHASE3 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Obesity
- Prediabetic State

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02681887
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2021-06
- **Final completion:** 2021-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02681887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02681887, "Effect of Melatonin on Cardiometabolic Risk- FULL". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02681887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*